Surveys, Registries, Interviews
Interview for people with stage III or IV ovarian cancer
Study Contact Information:
Verónica at [email protected]
Paid Research Interview Opportunity: Stage III or IV Ovarian Cancer Patients
About the Study
Modus Outcomes is seeking patients with III or IV ovarian cancer to participate in online interviews. We will ask you questions about your symptoms and how ovarian cancer impacts your life. Then, we will ask for feedback on questionnaires used in ovarian cancer studies. Your participation will help researchers better understand the experiences of people living with ovarian cancer and may help improve the design of clinical trials. If interested, contact Verónica at [email protected].
What the Study Involves
This is a qualitative interview study. You will begin by completing screening questions to confirm your diagnosis and determine if you are eligible to participate. If you are eligible and choose to enroll, you will participate in one interview that will take about 60 minutes. We will use an online platform such as Zoom. We can schedule the interview on a day and time that works for you.
During the interview, we will ask you questions about your ovarian cancer symptoms and how ovarian cancer impacts your life. Then, we will ask you to share feedback on patient questionnaires that are used in ovarian cancer studies. We will also ask basic questions about your health and demographic characteristics.
We will keep all the information that you share private and confidential. We will not report your name or other information that identifies you to anyone. You will be paid $175 for your participation.
Lead Researchers
Allison Baker, MPH, PhD, Research Scientist II at Modus Outcomes
Primary criteria (additional criteria apply):
- Age 18 years or older
- Living in the United States
- Able to speak, read, write, and understand English
- Diagnosed with III or IV ovarian cancer
- Currently in one of the following treatment groups: chemotherapy*, , or maintenance (maintenance treatment or active surveillance)
*Neoadjuvant treatment: Treatment meant to shrink a patient’s tumor before the main treatment; for example, chemotherapy before surgery. (Source: NCI Dictionary of Cancer Terms)
Primary criteria (additional criteria apply):
- History of second-line chemotherapy
- Current pregnancy
- Irritable bowel syndrome, Crohn’s disease, ulcerative colitis, celiac disease, or another inflammatory gastrointestinal condition
- Use of prescription pain medication for an indication other than ovarian cancer